These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 17023827

  • 1. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
    Rondinelli PI, Ribeiro Kde C, de Camargo B.
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
    [Abstract] [Full Text] [Related]

  • 2. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
    Ammann RA, Hirt A, Lüthy AR, Aebi C.
    Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
    [Abstract] [Full Text] [Related]

  • 3. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
    Ammann RA, Bodmer N, Hirt A, Niggli FK, Nadal D, Simon A, Ozsahin H, Kontny U, Kühne T, Popovic MB, Lüthy AR, Aebi C.
    J Clin Oncol; 2010 Apr 20; 28(12):2008-14. PubMed ID: 20231680
    [Abstract] [Full Text] [Related]

  • 4. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
    Akova M, Paesmans M, Calandra T, Viscoli C, International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer.
    Clin Infect Dis; 2005 Jan 15; 40(2):239-45. PubMed ID: 15655741
    [Abstract] [Full Text] [Related]

  • 5. [Bone marrow suppression--including guidelines for the appropriate use of G-CSF].
    Watanabe T.
    Gan To Kagaku Ryoho; 2003 Jun 15; 30(6):755-9. PubMed ID: 12852340
    [Abstract] [Full Text] [Related]

  • 6. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M, Thamlikitkul V.
    J Med Assoc Thai; 2003 Mar 15; 86(3):212-23. PubMed ID: 12757060
    [Abstract] [Full Text] [Related]

  • 7. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
    Baskaran ND, Gan GG, Adeeba K.
    Ann Hematol; 2008 Jul 15; 87(7):563-9. PubMed ID: 18437382
    [Abstract] [Full Text] [Related]

  • 8. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN, de Boo TM, Smit HJ, Biesma B, Wilschut FA, Cheragwandi SA, Termeer A, Hensing CA, Akkermans J, Adang EM, Bootsma GP, Tjan-Heijnen VC.
    J Clin Oncol; 2005 Nov 01; 23(31):7974-84. PubMed ID: 16258098
    [Abstract] [Full Text] [Related]

  • 9. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF, Krailo M, Chen Z, Feusner J.
    Pediatr Blood Cancer; 2005 Sep 01; 45(3):274-80. PubMed ID: 15806544
    [Abstract] [Full Text] [Related]

  • 10. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.
    Santolaya ME, Alvarez AM, Avilés CL, Becker A, Mosso C, O'Ryan M, Payá E, Salgado C, Silva P, Topelberg S, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M.
    Pediatr Infect Dis J; 2007 Sep 01; 26(9):794-8. PubMed ID: 17721373
    [Abstract] [Full Text] [Related]

  • 11. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM, Moneer MM, Ismail MM, Shalaby LM, El-Mahallawy HA.
    J Pediatr Hematol Oncol; 2007 Mar 01; 29(3):131-6. PubMed ID: 17356388
    [Abstract] [Full Text] [Related]

  • 12. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
    Ammann RA, Hirt A, Lüthy AR, Aebi C.
    Pediatr Infect Dis J; 2004 Jan 01; 23(1):61-7. PubMed ID: 14743049
    [Abstract] [Full Text] [Related]

  • 13. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
    Agyeman P, Aebi C, Hirt A, Niggli FK, Nadal D, Simon A, Ozsahin H, Kontny U, Kühne T, Beck Popovic M, Leibundgut K, Bodmer N, Ammann RA.
    Pediatr Infect Dis J; 2011 Jul 01; 30(7):e114-9. PubMed ID: 21394050
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR.
    J Clin Oncol; 2004 Aug 15; 22(16):3350-6. PubMed ID: 15310780
    [Abstract] [Full Text] [Related]

  • 15. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
    Tezcan G, Kupesiz A, Ozturk F, Ogunc D, Gultekin M, Yesilipek A, Hazar V.
    Pediatr Hematol Oncol; 2006 Aug 15; 23(3):217-29. PubMed ID: 16517538
    [Abstract] [Full Text] [Related]

  • 16. [Criteria of low risk of mortality in children with neutropenia and fever during cancer chemotherapy].
    Paganini HR, Rodríguez Brieshcke T, Zubizarreta P, Latella A, Firpo V, Fernandez C, Armada A, Casimir L, Debbag R.
    Medicina (B Aires); 2001 Aug 15; 61(1):63-6. PubMed ID: 11265626
    [Abstract] [Full Text] [Related]

  • 17. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
    Shayne M, Culakova E, Poniewierski MS, Wolff D, Dale DC, Crawford J, Lyman GH.
    Cancer; 2007 Oct 01; 110(7):1611-20. PubMed ID: 17705197
    [Abstract] [Full Text] [Related]

  • 18. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
    Lyman GH, Delgado DJ.
    Cancer; 2003 Dec 01; 98(11):2402-9. PubMed ID: 14635075
    [Abstract] [Full Text] [Related]

  • 19. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV.
    Cancer; 1999 Jul 01; 86(1):126-34. PubMed ID: 10391572
    [Abstract] [Full Text] [Related]

  • 20. Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.
    Laskey RA, Poniewierski MS, Lopez MA, Hanna RK, Secord AA, Gehrig PA, Lyman GH, Havrilesky LJ.
    Gynecol Oncol; 2012 Jun 01; 125(3):625-30. PubMed ID: 22426251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.